These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

755 related articles for article (PubMed ID: 19222455)

  • 1. Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies.
    Hauschild A; Stockfleth E; Popp G; Borrosch F; Brüning H; Dominicus R; Mensing H; Reinhold U; Reich K; Moor AC; Stocker M; Ortland C; Brunnert M; Szeimies RM
    Br J Dermatol; 2009 May; 160(5):1066-74. PubMed ID: 19222455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months data.
    Szeimies RM; Stockfleth E; Popp G; Borrosch F; Brüning H; Dominicus R; Mensing H; Reinhold U; Reich K; Moor AC; Stocker M; Ortland C; Brunnert M; Hauschild A
    Br J Dermatol; 2010 Feb; 162(2):410-4. PubMed ID: 19804593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective photodynamic therapy of actinic keratoses on the head and face with a novel, self-adhesive 5-aminolaevulinic acid patch.
    Hauschild A; Popp G; Stockfleth E; Meyer KG; Imberger D; Mohr P; Itschert G; Kaufmann R; Neuber K; Frambach Y; Gollnick H; Brunnert M; Stocker M; Ortland C; Karrer S
    Exp Dermatol; 2009 Feb; 18(2):116-21. PubMed ID: 18643849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
    Moloney FJ; Collins P
    Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of retinoid pretreatment on outcomes of patients treated by photodynamic therapy for actinic keratosis of the hand and forearm.
    Galitzer BI
    J Drugs Dermatol; 2011 Oct; 10(10):1124-32. PubMed ID: 21968662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.
    Reinhold U; Dirschka T; Ostendorf R; Aschoff R; Berking C; Philipp-Dormston WG; Hahn S; Lau K; Jäger A; Schmitz B; Lübbert H; Szeimies RM
    Br J Dermatol; 2016 Oct; 175(4):696-705. PubMed ID: 26921093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
    Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
    Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of actinic keratoses on the dorsum of the hands: ALA-PDT versus diclofenac 3% gel followed by ALA-PDT. A placebo-controlled, double-blind, pilot study.
    Van der Geer S; Krekels GA
    J Dermatolog Treat; 2009; 20(5):259-65. PubMed ID: 19370466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, randomized, vehicle-controlled phase 2 study of blue light photodynamic therapy with aminolevulinic acid HCl 20% topical solution for the treatment of actinic keratoses on the upper extremities: the effect of occlusion during the drug incubation period.
    Schmieder GJ; Huang EY; Jarratt M
    J Drugs Dermatol; 2012 Dec; 11(12):1483-9. PubMed ID: 23377520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials.
    Piacquadio DJ; Chen DM; Farber HF; Fowler JF; Glazer SD; Goodman JJ; Hruza LL; Jeffes EW; Ling MR; Phillips TJ; Rallis TM; Scher RK; Taylor CR; Weinstein GD
    Arch Dermatol; 2004 Jan; 140(1):41-6. PubMed ID: 14732659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities.
    Kaufmann R; Spelman L; Weightman W; Reifenberger J; Szeimies RM; Verhaeghe E; Kerrouche N; Sorba V; Villemagne H; Rhodes LE
    Br J Dermatol; 2008 May; 158(5):994-9. PubMed ID: 18341663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, blinded, bilateral intraindividual, vehicle-controlled trial of the use of photodynamic therapy with 5-aminolevulinic acid and blue light for the treatment of actinic keratoses of the upper extremities.
    Taub AF; Garretson CB
    J Drugs Dermatol; 2011 Sep; 10(9):1049-56. PubMed ID: 22052276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminolaevulinic acid diffusion characteristics in 'in vitro' normal human skin and actinic keratosis: implications for topical photodynamic therapy.
    McLoone N; Donnelly RF; Walsh M; Dolan OM; McLoone S; McKenna K; McCarron PA
    Photodermatol Photoimmunol Photomed; 2008 Aug; 24(4):183-90. PubMed ID: 18717959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study.
    Radakovic-Fijan S; Blecha-Thalhammer U; Kittler H; Hönigsmann H; Tanew A
    J Am Acad Dermatol; 2005 Nov; 53(5):823-7. PubMed ID: 16243131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study.
    Szeimies RM; Radny P; Sebastian M; Borrosch F; Dirschka T; Krähn-Senftleben G; Reich K; Pabst G; Voss D; Foguet M; Gahlmann R; Lübbert H; Reinhold U
    Br J Dermatol; 2010 Aug; 163(2):386-94. PubMed ID: 20518784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate.
    Neittaanmäki-Perttu N; Karppinen TT; Grönroos M; Tani TT; Snellman E
    Br J Dermatol; 2014 Nov; 171(5):1172-80. PubMed ID: 25109244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
    Rubel DM; Spelman L; Murrell DF; See JA; Hewitt D; Foley P; Bosc C; Kerob D; Kerrouche N; Wulf HC; Shumack S
    Br J Dermatol; 2014 Nov; 171(5):1164-71. PubMed ID: 24861492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical aminolaevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study.
    Radakovic-Fijan S; Blecha-Thalhammer U; Schleyer V; Szeimies RM; Zwingers T; Hönigsmann H; Tanew A
    Br J Dermatol; 2005 Feb; 152(2):279-83. PubMed ID: 15727639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractionated illumination improves the outcome in the treatment of precancerous lesions with photodynamic therapy.
    Puizina-Ivić N; Zorc H; Vanjaka-Rogosić L; Mirić L; Persin A
    Coll Antropol; 2008 Oct; 32 Suppl 2():67-73. PubMed ID: 19138010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.